−3.05 TWD
−129.23 M TWD
941.00 K TWD
About STEMINENT BIOTHERAPEUTICS INC
Sector
Industry
CEO
Ling Mei Wang
Website
Headquarters
Taipei
Founded
2007
ISIN
TW0007729006
FIGI
BBG01LSGSNR6
Steminent Biotherapeutics, Inc. develops novel cellular therapeutics and engages in the research and development of new stem cell drugs. Its products include stemchymal, stemchymal therapeutic advantages and stemchymal application fields. The company was founded on December 18, 2007 and is headquartered in Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 7729 is 23.10 TWD — it has decreased by −0.43% in the past 24 hours. Watch STEMINENT BIOTHERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange STEMINENT BIOTHERAPEUTICS INC stocks are traded under the ticker 7729.
7729 stock has fallen by −0.65% compared to the previous week, the month change is a 2.45% rise, over the last year STEMINENT BIOTHERAPEUTICS INC has showed a −49.12% decrease.
7729 reached its all-time high on Mar 11, 2024 with the price of 53.00 TWD, and its all-time low was 19.90 TWD and was reached on Nov 5, 2024. View more price dynamics on 7729 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
7729 stock is 3.08% volatile and has beta coefficient of −0.14. Track STEMINENT BIOTHERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is STEMINENT BIOTHERAPEUTICS INC there?
Yes, you can track STEMINENT BIOTHERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
7729 net income for the last half-year is −83.60 M TWD, while the previous report showed −87.07 M TWD of net income which accounts for 3.98% change. Track more STEMINENT BIOTHERAPEUTICS INC financial stats to get the full picture.
No, 7729 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 55.00 employees. See our rating of the largest employees — is STEMINENT BIOTHERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STEMINENT BIOTHERAPEUTICS INC EBITDA is −158.91 M TWD, and current EBITDA margin is −12.69 K%. See more stats in STEMINENT BIOTHERAPEUTICS INC financial statements.
Like other stocks, 7729 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STEMINENT BIOTHERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STEMINENT BIOTHERAPEUTICS INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STEMINENT BIOTHERAPEUTICS INC stock shows the strong sell signal. See more of STEMINENT BIOTHERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.